Clinical Trial Update: Axillary Nodal Burden in HER2+ and TNBC

View source ↗

Summary

A completed clinical trial update evaluating axillary nodal burden in HER2-positive and triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Gangnam Severance Hospital | Conditions: Breast Cancer | Status: COMPLETED